{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:15Z","timestamp":1790739795873,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Introduction<\/jats:title><jats:p>Evacuation of infected fluid in pleural infections is essential. To date, the use of an intrapleural fibrinolytic agent such as urokinase and DNase has not yet been assessed in infections managed by repeated therapeutic thoracentesis (RTT).<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>We performed a retrospective comparative study of two successive cohorts of consecutive patients with pleural infections from 2001 to 2018. Between 2001 and 2010, patients had RTT with intrapleural urokinase (RTT-U). After 2011, patients received intrapleural urokinase and DNase with RTT (RTT-UD). Data were collected through a standardized questionnaire.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>One hundred and thirty-three patients were included: 93 were men and the mean age was 59 years (standard deviation 17.2). Eighty-one patients were treated with a combination of intrapleural urokinase and DNase, and 52 were treated with intrapleural urokinase only. In the RTT-UD, RTT failure occurred in 14 patients (17%) compared to 10 (19%) in the RTT-U group (<jats:italic>P<\/jats:italic>= 0.82). There was no difference between the two groups in intensive care unit admission, surgical referrals or in-hospital mortality. RTT-UD was associated with faster time to apyrexia (aOR = 0.51, 95%CI [0.37\u20130.72]), a reduced length of hospital stay (aOR = 0.61, 95%CI [0.52\u20130.73]) and a higher volume of total pleural fluid retrieved (aOR = 1.38, 95%CI [1.02\u20131.88]). Complications were rare with only one hemothorax in the RTT-UD group and no pneumothorax requiring drainage in either group.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>Compared to urokinase only, intrapleural use of urokinase and DNase in RTT was associated with quicker defervescence, shorter hospital stay and increased volumes of pleural fluid drained. Randomized controlled trials evaluating urokinase and DNase with RTT technique would be required to confirm these results.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0257339","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T18:26:58Z","timestamp":1632248818000},"page":"e0257339","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-7305","authenticated-orcid":true,"given":"David","family":"Luque Paz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsega","family":"Bayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-361X","authenticated-orcid":true,"given":"Florence","family":"Poizeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Lederlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallorie","family":"Kerjouan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"de Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Letheulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Jouneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"issue":"9","key":"pone.0257339.ref001","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa042473","article-title":"U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection.","volume":"352","author":"NA Maskell","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"pone.0257339.ref002","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1378\/chest.13-1558","article-title":"A Clinical Score (RAPID) to Identify Those at Risk for Poor Outcome at Presentation in Patients With Pleural Infection.","volume":"145","author":"NM Rahman","year":"2014","journal-title":"Chest"},{"issue":"8","key":"pone.0257339.ref003","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thx.2010.156406","article-title":"Emergence of parapneumonic empyema in the USA.","volume":"66","author":"CG Grijalva","year":"2011","journal-title":"Thorax"},{"key":"pone.0257339.ref004","article-title":"Trends in the Incidence, Etiology, Treatment, and Outcomes of Pleural Infections in Adults Over a Decade in a Finnish University Hospital.","author":"A Lehtom\u00e4ki","year":"2019","journal-title":"Scandinavian Journal of Surgery"},{"issue":"2","key":"pone.0257339.ref005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1155\/2008\/975312","article-title":"Empyema: An increasing concern in Canada.","volume":"15","author":"C Finley","year":"2008","journal-title":"Can Respir J."},{"issue":"Suppl 2","key":"pone.0257339.ref006","doi-asserted-by":"crossref","first-page":"ii41","DOI":"10.1136\/thx.2010.137000","article-title":"Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010.","volume":"65","author":"HE Davies","year":"2010","journal-title":"Thorax"},{"issue":"4","key":"pone.0257339.ref007","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1378\/chest.118.4.1158","article-title":"Medical and surgical treatment of parapneumonic effusions\u202f: an evidence-based guideline.","volume":"118","author":"GL Colice","year":"2000","journal-title":"Chest"},{"issue":"6","key":"pone.0257339.ref008","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","article-title":"The American Association for Thoracic Surgery consensus guidelines for the management of empyema","volume":"153","author":"KR Shen","year":"2017","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"1","key":"pone.0257339.ref009","doi-asserted-by":"crossref","first-page":"e84788","DOI":"10.1371\/journal.pone.0084788","article-title":"Iterative thoracentesis as first-line treatment of complicated parapneumonic effusion.","volume":"9","author":"J Letheulle","year":"2014","journal-title":"PLoS ONE"},{"issue":"10","key":"pone.0257339.ref010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/thx.47.10.821","article-title":"Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage.","volume":"47","author":"HK Storm","year":"1992","journal-title":"Thorax"},{"issue":"6","key":"pone.0257339.ref011","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection.","volume":"365","author":"NM Rahman","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"pone.0257339.ref012","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.pupt.2006.08.001","article-title":"Intrapleural fibrinolytic therapy for pleural infection","volume":"20","author":"D Bouros","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"pone.0257339.ref013","first-page":"999","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.","volume":"7","author":"F Piccolo","year":"2015","journal-title":"J Thorac Dis."},{"issue":"6","key":"pone.0257339.ref014","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00408-015-9807-6","article-title":"Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study","volume":"193","author":"C Alem\u00e1n","year":"2015","journal-title":"Lung"},{"issue":"10","key":"pone.0257339.ref015","article-title":"Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.","volume":"2019","author":"ES Altmann","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"pone.0257339.ref016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001887","article-title":"Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions\u2014analysis of predictors for failure of therapy and bleeding: a cohort study.","volume":"3","author":"S Abu-Daff","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0257339.ref017","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.155.1.9001327","article-title":"Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study","volume":"155","author":"D Bouros","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"pone.0257339.ref018","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1742-1241.2001.tb11156.x","article-title":"Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial.","volume":"55","author":"B Tuncozgur","year":"2001","journal-title":"Int J Clin Pract."},{"issue":"9","key":"pone.0257339.ref019","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1513\/AnnalsATS.201602-127OC","article-title":"Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.","volume":"13","author":"A Majid","year":"2016","journal-title":"Ann Am Thorac Soc."},{"issue":"3","key":"pone.0257339.ref020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/crj.12068","article-title":"Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.","volume":"8","author":"W Nie","year":"2014","journal-title":"Clin Respir J."},{"issue":"4","key":"pone.0257339.ref021","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/MCP.0b013e3283531149","article-title":"Intrapleural agents for pleural infection: fibrinolytics and beyond.","volume":"18","author":"NM Rahman","year":"2012","journal-title":"Curr Opin Pulm Med."},{"key":"pone.0257339.ref022","article-title":"Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement","author":"U Chaddha","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"pone.0257339.ref023","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01550-2018","article-title":"Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial","volume":"54","author":"R Luengo-Fernandez","year":"2019","journal-title":"Eur Respir J"},{"key":"pone.0257339.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2019.01.001","article-title":"Alteplase and DNase for the treatment of pleural empyema in rats","volume":"55","author":"M Gehlen","year":"2019","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"6","key":"pone.0257339.ref025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1378\/chest.129.6.1577","article-title":"Tissue Plasminogen Activator Combined With Human Recombinant Deoxyribonuclease Is Effective Therapy for Empyema in a Rabbit Model.","volume":"129","author":"Z Zhu","year":"2006","journal-title":"Chest"},{"issue":"1","key":"pone.0257339.ref026","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1469-0691.2005.01294.x","article-title":"Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores","volume":"12","author":"S-H Kim","year":"2006","journal-title":"Clinical Microbiology and Infection"},{"issue":"2","key":"pone.0257339.ref027","article-title":"Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy","volume":"61","author":"C-C Lee","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pone.0257339.ref028","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s001340050928","article-title":"A prospective study of fever in the intensive care unit.","volume":"25","author":"B Circiumaru","year":"1999","journal-title":"Intensive Care Medicine."},{"issue":"5","key":"pone.0257339.ref029","first-page":"1531","article-title":"Occurrence and outcome of fever in critically ill adults*: Critical Care Medicine.","volume":"36","author":"KB Laupland","year":"2008"},{"issue":"1","key":"pone.0257339.ref030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1378\/chest.12-2843","article-title":"Persistent Fever in the ICU.","volume":"145","author":"T Rehman","year":"2014","journal-title":"Chest"},{"issue":"2","key":"pone.0257339.ref031","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.11-3071","article-title":"Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.","volume":"142","author":"S Janda","year":"2012","journal-title":"Chest"},{"issue":"6","key":"pone.0257339.ref032","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/17476348.2018.1475234","article-title":"Management of pleural infections.","volume":"12","author":"L Ferreiro","year":"2018","journal-title":"Expert Review of Respiratory Medicine."},{"issue":"6","key":"pone.0257339.ref033","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1378\/chest.116.6.1703","article-title":"The Utility of Daily Therapeutic Thoracentesis for the Treatment of Early Empyema.","volume":"116","author":"S Sasse","year":"1999","journal-title":"Chest"},{"issue":"4","key":"pone.0257339.ref034","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MCP.0000000000000171","article-title":"Repeated therapeutic thoracentesis to manage complicated parapneumonic effusions.","volume":"21","author":"S Jouneau","year":"2015","journal-title":"Curr Opin Pulm Med."},{"issue":"3","key":"pone.0257339.ref035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-5223(19)36256-7","article-title":"Treatment of spontaneous bacterial empyema thoracis.","volume":"94","author":"AK Mandal","year":"1987","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"2","key":"pone.0257339.ref036","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2007-1013115","article-title":"Minimally invasive treatment of thoracic empyema.","volume":"47","author":"TA Simmers","year":"1999","journal-title":"Thorac Cardiovasc Surg."},{"issue":"8","key":"pone.0257339.ref037","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1513\/AnnalsATS.202001-076OC","article-title":"Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.","volume":"17","author":"F Kheir","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"pone.0257339.ref038","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1513\/AnnalsATS.201711-848PS","article-title":"Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.","volume":"15","author":"S Idell","year":"2018","journal-title":"Ann Am Thorac Soc."},{"issue":"4","key":"pone.0257339.ref039","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/qjmed\/89.4.285","article-title":"The clinical course and management of thoracic empyema","volume":"89","author":"AD Ferguson","year":"1996","journal-title":"QJM"},{"issue":"5","key":"pone.0257339.ref040","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1378\/chest.112.5.1291","article-title":"Is pH Paper an Acceptable, Low-Cost Alternative to the Blood Gas Analyzer for Determining Pleural Fluid pH?","volume":"112","author":"EP Lesho","year":"1997","journal-title":"Chest"},{"key":"pone.0257339.ref041","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2016.11.012","article-title":"Diagnosis of complicated parapneumonic effusion by pleural pH measurement is jeopardized by inadequate physician knowledge and guideline-discordant laboratory practice.","volume":"122","author":"L Ng","year":"2017","journal-title":"Respiratory Medicine."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T04:47:38Z","timestamp":1699505258000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257339"}},"subtitle":[],"editor":[{"given":"Robert Jeenchen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0257339","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]}}}